CLINICAL_TRIALS
trial_result
· 2019-04-16
Clinical Trial Update: An Open Label Phase 2 Study of ManNAc in Subjects With GNE Myopathy [Phase 2]
Summary
Phase 2 open-label trial of ManNAc in GNE myopathy completed; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Human Genome Research Institute (NHGRI) | Conditions: GNE Myopathy | Phase 2 | Status: COMPLETED | Results posted: 2019-04-16